Argenica Therapeutics dose test raises hopes for stroke victims
Argenica Therapeutics (ASX:AGN), a biotech firm focused on the advancement of therapies…
Mon, 20 May | Close | Change |
4:44pm | 7,863.7 | 49.3 |
Closed at Mon, 20 May 6:11pm |
S&P/ASX Sm. Ords. | 3,070.7 | 27.1 | 0.89% |
All Ordinaries | 8,132.1 | 49.8 | 0.62% |
S&P/ASX 100 | 6,600.5 | 37.7 | 0.57% |